Back to Search
Start Over
First amyloid β1‐42 certified reference material for re‐calibrating commercial immunoassays
- Source :
- Alzheimer's & Dementia
- Publication Year :
- 2020
- Publisher :
- Wiley, 2020.
-
Abstract
- Introduction: Reference materials based on human cerebrospinal fluid were certified for the mass concentration of amyloid beta (Aβ)1-42 (Aβ 42). They are intended to be used to calibrate diagnostic assays for Aβ 42. Methods: The three certified reference materials (CRMs), ERM-DA480/IFCC, ERM-DA481/IFCC and ERM-DA482/IFCC, were prepared at three concentration levels and characterized using isotope dilution mass spectrometry methods. Roche, EUROIMMUN, and Fujirebio used the three CRMs to re-calibrate their immunoassays. Results: The certified Aβ 42 mass concentrations in ERM-DA480/IFCC, ERM-DA481/IFCC, and ERM-DA482/IFCC are 0.45, 0.72, and 1.22 μg/L, respectively, with expanded uncertainties (k = 2) of 0.07, 0.11, and 0.18 μg/L, respectively. Before re-calibration, a good correlation (Pearson's r > 0.97), yet large biases, were observed between results from different commercial assays. After re-calibration the between-assay bias was reduced to
- Subjects :
- 0301 basic medicine
Epidemiology
Neuroscience(all)
Amyloid β1 42
Isotope dilution
03 medical and health sciences
Cellular and Molecular Neuroscience
0302 clinical medicine
Developmental Neuroscience
Humans
Mass concentration (chemistry)
commercial immunoassays
amyloid beta peptide
Immunoassay
Amyloid beta-Peptides
Chromatography
Featured Articles
Chemistry
Health Policy
Reference Standards
Featured Article
Alzheimer's disease
Psychiatry and Mental health
030104 developmental biology
Certified reference materials
Calibration
certified reference material
Neurology (clinical)
Geriatrics and Gerontology
030217 neurology & neurosurgery
Subjects
Details
- ISSN :
- 15525279 and 15525260
- Volume :
- 16
- Database :
- OpenAIRE
- Journal :
- Alzheimer's & Dementia
- Accession number :
- edsair.doi.dedup.....879f1c6047da3ababd839962d456ac6a
- Full Text :
- https://doi.org/10.1002/alz.12145